Sequence 6

DRUG3 trials

Sponsors

Yuhan Corporation, Samyang Biopharmaceuticals Corporation, Chong Kun Dang Pharmaceutical

Conditions

DyslipidemiasHealthyHyperlipidemiaHypertension

Phase 1

Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects

CompletedNCT01332890

Yuhan CorporationHealthy

Start: 2011-04-30End: 2011-08-31Updated: 2014-07-10

Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)

CompletedNCT01353404

Samyang Biopharmaceuticals CorporationHyperlipidemia

Start: 2011-06-30End: 2011-08-31Updated: 2012-12-18

A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

Chong Kun Dang PharmaceuticalDyslipidemias, Hypertension

Start: 2018-08-31End: 2019-01-15Target: 30Updated: 2018-11-01